darunavir has been researched along with HIV-Associated Lipodystrophy Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guaraldi, G; Santoro, A; Stentarelli, C; Zona, S | 1 |
| Carli, F; Cossarizza, A; Garau, M; Garlassi, E; Guaraldi, G; Lattanzi, A; Nardini, G; Orlando, G; Termini, R; Vernacotola, L; Zona, S | 1 |
| Algarte Genin, M; Cuzin, L; de Kerviler, E; Flandre, P; Inaoui, R; Katlama, C; Kolta, S; Meynard, JL; Ponscarme, D; Slama, L; Valantin, MA | 1 |
1 review(s) available for darunavir and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
HIV-associated lipodystrophy: impact of antiretroviral therapy.
Topics: Adiposity; Aging; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Darunavir; Drug Combinations; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Nucleosides; Oligopeptides; Pyridines; Pyrrolidinones; Raltegravir Potassium; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Sulfonamides | 2013 |
2 trial(s) available for darunavir and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: the Monarch randomized controlled trial.
Topics: Adult; Antiretroviral Therapy, Highly Active; Body Fat Distribution; Bone Density; Darunavir; Female; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; Ritonavir; Sulfonamides; Treatment Outcome | 2014 |
Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 substudy.
Topics: Adult; Body Fat Distribution; Darunavir; Drug Therapy, Combination; Female; France; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; Ritonavir; Sulfonamides | 2012 |